XRP news today: SEC Delays Decisions on Five Crypto ETFs Until 2025
The US Securities and Exchange Commission (SEC) has delayed decisions on five crypto-related exchange-traded funds (ETFs) applications. This move was anticipated by analysts, who expect final rulings by October 2025. The delayed ETFs include Franklin Templeton’s spot Solana (SOL) and XRP ETFs, Grayscale spot Hedera (HBAR) ETF, BitwiseBITB-- spot Dogecoin (DOGE) ETF, and the staking provisions associated with the FidelityFMUB-- spot Ethereum (ETH) ETF.
According to analysts, the SEC typically follows a series of statutory deadlines for ETF approvals, which include 45, 90, 180, and 240 days after the publication of a 19b-4 filing in the Federal Register. Many of the delayed products still face their final deadlines between the third and fourth quarters of 2025. The updated calendar shows that the Franklin Spot XRP ETF now faces a final decision deadline of November 5, 2025, while the Franklin Spot Solana ETF awaits a ruling by October 7, 2025. The Grayscale Hedera ETF and Bitwise Dogecoin ETF both have final deadlines scheduled for October 8, 2025. The Ethereum staking provisions tied to Fidelity’s proposal are currently pending, with earlier stages completed as of April 2025.
The delays are in line with standard SEC practice, extending the agency’s timeline to continue evaluation without issuing denials. Analysts expect that the SEC will likely make decisions on these ETFs after Chair Paul Atkins officially took office, which happened very recently. The SEC has been taking outside meetings with people, probably coming up with a strategy. After that, likely approvals.
According to the analyst's forecast, the SEC is expected to take up to the last deadline to approve most altcoin-related ETFs. There is also a possibility of further delays this week, with more deadlines approaching on roughly 72 crypto ETFs awaiting the SEC’s approval.
Quickly understand the history and background of various well-known coins
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments
No comments yet